Quoin Pharmaceuticals Ltd (QNRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access QNRX Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Quoin Pharmaceuticals Ltd balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent3.85
Short-term Investments, Total6.95
Cash & Short-term Investments9.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.00
Total Current Assets11.64
Intangible Assets0.33
Tax Assets, Noncurrent0.00
Prepaid Expense, Noncurrent, Total PR0.84
Other Assets, Noncurrent0.00
Total Assets11.97
Liabilities
Accounts Payable, Current AC3.11
Accrued Liabilities, Current1.76
Other Liabilities, Current1.75
Total Current Liabilities6.61
Total Long-term Debt0.00
Due to Officers or Stockholders, Noncurrent1.42
Total Liabilities8.04
Stockholders' Equity
Additional Paid In Capital Common Stock85.27
Retained Earnings / Accumulated Deficit-81.34
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity3.93
Total Stockholder's Equity3.93
Liabilities & Stockholder's Equity11.97
4 historic quarters locked

Sign in to unlock the full Quoin Pharmaceuticals Ltd balance sheet history.

About Quoin Pharmaceuticals Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-097064

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.